Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

August 01, 2001; Volume 29,Issue 8

Editorial

  • You have access
    James R. Halpert
    Drug Metabolism and Disposition August 2001, 29 (8) 1073;

Articles

  • You have access
    The Use of a High-Volume Screening Procedure to Assess the Effects of Dietary Flavonoids on Human CYP1A1 Expression
    Scott W. Allen, Lisa Mueller, Susanne N. Williams, Linda C. Quattrochi and Judy Raucy
    Drug Metabolism and Disposition August 2001, 29 (8) 1074-1079;
  • You have access
    Evaluation of the Interaction of Loratadine and desloratadine with P-glycoprotein
    Er-jia Wang, Christopher N. Casciano, Robert P. Clement and William W. Johnson
    Drug Metabolism and Disposition August 2001, 29 (8) 1080-1083;
  • You have access
    Bisphenol A Glucuronide, a Major Metabolite in Rat Bile after Liver Perfusion
    Hiroki Inoue, Hiroshi Yokota, Tsunehisa Makino, Akira Yuasa and Seiyu Kato
    Drug Metabolism and Disposition August 2001, 29 (8) 1084-1087;
  • You have access
    Cytochrome P4502E1 Induction Increases Thioacetamide Liver Injury in Diet-Restricted Rats
    Shashi K. Ramaiah, Udayan Apte and Harihara M. Mehendale
    Drug Metabolism and Disposition August 2001, 29 (8) 1088-1095;
  • You have access
    Glucuronidation of 1-Hydroxypyrene by Human Liver Microsomes and Human UDP-Glucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: Development of a High-Sensitivity Glucuronidation Assay for Human Tissue
    Leena Luukkanen, Jouni Mikkola, Tarja Forsman, Päivi Taavitsainen, Jyrki Taskinen and Eivor Elovaara
    Drug Metabolism and Disposition August 2001, 29 (8) 1096-1101;
  • You have access
    Escitalopram (S-Citalopram) and Its Metabolites in Vitro: Cytochromes Mediating Biotransformation, Inhibitory Effects, and Comparison to R-Citalopram
    Lisa L. von Moltke, David J. Greenblatt, Gina M. Giancarlo, Brian W. Granda, Jerold S. Harmatz and Richard I. Shader
    Drug Metabolism and Disposition August 2001, 29 (8) 1102-1109;
  • You have access
    Inhibition and Inactivation of Human Cytochrome P450 Isoforms by Phenethyl Isothiocyanate
    Miki Nakajima, Ryoko Yoshida, Noriaki Shimada, Hiroshi Yamazaki and Tsuyoshi Yokoi
    Drug Metabolism and Disposition August 2001, 29 (8) 1110-1113;
  • You have access
    Carbinolamines, Imines, and Oxazolidines from Fluorinated Propranolol Analogs. 19F NMR and Mass Spectral Characterization and Evidence for Formation as Intermediates in Cytochrome P450-Catalyzed N-Dealkylation
    Alana L. Upthagrove and Wendel L. Nelson
    Drug Metabolism and Disposition August 2001, 29 (8) 1114-1122;
  • You have access
    Evaluation of the Contribution of Cytochrome P450 3A4 to Human Liver Microsomal Bupropion Hydroxylation
    Stephanie R. Faucette, Roy L. Hawke, Stacy S. Shord, Edward L. Lecluyse and Celeste M. Lindley
    Drug Metabolism and Disposition August 2001, 29 (8) 1123-1129;
  • You have access
    Transcriptional Regulation of Rat Hepatic Aryl Sulfotransferase (SULT1A1) Gene Expression by Glucocorticoids
    Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-Morris
    Drug Metabolism and Disposition August 2001, 29 (8) 1130-1135;
  • You have access
    Pharmacokinetics, Metabolism, and Excretion of Linezolid following an Oral Dose of [14C]Linezolid to Healthy Human Subjects
    J. G. Slatter, D. J. Stalker, K. L. Feenstra, I. R. Welshman, J. B. Bruss, J. P. Sams, M. G. Johnson, P. E. Sanders, M. J. Hauer, P. E. Fagerness, R. P. Stryd, G. W. Peng and E. M. Shobe
    Drug Metabolism and Disposition August 2001, 29 (8) 1136-1145;
  • You have access
    Identification of Cytochrome P-450 Isoforms Responsible for cis-Tramadol Metabolism in Human Liver Microsomes
    Vangala Subrahmanyam, Anthony B. Renwick, David G. Walters, Philip J. Young, Roger J. Price, Alfred P. Tonelli and Brian G. Lake
    Drug Metabolism and Disposition August 2001, 29 (8) 1146-1155;
  • You have access
    Inhibition of Rat Liver Microsomal CYP1A2 and CYP2B1 Activity by N-(2-Heptyl)-N-methyl-propargylamine and by N-(2-Heptyl)-propargylamine
    L. E. Dyck and B. A. Davis
    Drug Metabolism and Disposition August 2001, 29 (8) 1156-1161;
  • You have access
    Biotransformation, Excretion Kinetics, and Tissue Distribution of an N-Pyrrolo[1,2-c]imidazolylphenyl Sulfonamide Herbicide in Rats
    Mehran F. Moghaddam, Alethia Brown, Boiana O. Budevska, Zamas Lam and William G. Payne
    Drug Metabolism and Disposition August 2001, 29 (8) 1162-1170;

Erratum

  • You have access
    Correction to “Dapsone Activation of CYP2C9-Mediated Metabolism: Evidence for Activation of Multiple Substrates and a Two-Site Model”
    Drug Metabolism and Disposition August 2001, 29 (8) 1171;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 29 (8)
Drug Metabolism and Disposition
Vol. 29, Issue 8
1 Aug 2001
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Editorial
  • Articles
  • Erratum
  • Most Read
Loading
  • Predictable Cross-Species Translation of GalNAc-Conjugated siRNA
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • ADME of Therapeutic Proteins
  • PK and Biodistribution of Therapeutic Proteins
  • An IQ Perspective of Therapeutic Protein Biotransformation
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics